Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BMS Voluntarily Recalls Rheumatoid Arthritis Drug In Japan

This article was originally published in PharmAsia News

Executive Summary

Bristol-Myers Squibb voluntarily recalled rheumatoid arthritis drug Kenacort-A (triamcinolone) 50gm/5ml and 40mg/1ml injections in Japan, due to reported swelling and aches in administrated areas. Although such symptoms are listed in the package insert, the company received multiple reports of such cases in Japan and decided to recall the products. BMS also halted shipping the products pending investigation results. The company estimated around 10,000 units stocked in Japanese medical facilities nationwide. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts